These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 27999794)
1. HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis. Zhang H; Zhu B; Zhang H; Liang J; Zeng W Biomed Res Int; 2016; 2016():3417976. PubMed ID: 27999794 [No Abstract] [Full Text] [Related]
2. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis. Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review. Li M; Li J; Li P; Li H; Su T; Zhu R; Gong J J Gastroenterol Hepatol; 2012 Oct; 27(10):1561-8. PubMed ID: 22694354 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis. Wang Z; Sheng YY; Dong QZ; Qin LX World J Gastroenterol; 2016 Mar; 22(10):3038-51. PubMed ID: 26973400 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism. Zhou Y; Zhou Q; Lin Q; Chen R; Gong Y; Liu Y; Yu M; Zeng B; Li K; Chen R; Li Z Int J Cancer; 2013 Oct; 133(8):1867-75. PubMed ID: 23564396 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma. Matsumoto K; Onoyama T; Kawata S; Takeda Y; Harada K; Ikebuchi Y; Ueki M; Miura N; Yashima K; Koda M; Sakamoto T; Endo M; Horie Y; Murawaki Y Intern Med; 2014; 53(7):651-4. PubMed ID: 24694471 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies. Li H; Hu B; Zhou ZQ; Guan J; Zhang ZY; Zhou GW World J Surg Oncol; 2015 Apr; 13():161. PubMed ID: 25903488 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea. Lee BS; Park EC; Park SW; Nam CM; Roh J World J Gastroenterol; 2015 Jan; 21(2):502-10. PubMed ID: 25593465 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan. Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326 [TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of hepatitis virus B seropositive in the patients with cholangiocarcinoma: a summary. Wiwanitkit V Asian Pac J Cancer Prev; 2005; 6(1):27-8. PubMed ID: 15780027 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. Zhou Y; Zhao Y; Li B; Huang J; Wu L; Xu D; Yang J; He J BMC Cancer; 2012 Jul; 12():289. PubMed ID: 22799744 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China. Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244 [TBL] [Abstract][Full Text] [Related]
14. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas. Qu Z; Cui N; Qin M; Wu X Asia Pac J Clin Oncol; 2012 Mar; 8(1):83-7. PubMed ID: 22369448 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes. Song Z; Lin S; Wu X; Ren X; Wu Y; Wen H; Qian B; Lin H; Huang Y; Zhao C; Wang N; Huang Y; Peng B; Li X; Peng H; Shen S Hepatol Int; 2023 Oct; 17(5):1300-1317. PubMed ID: 37368186 [TBL] [Abstract][Full Text] [Related]
16. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study. Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883 [TBL] [Abstract][Full Text] [Related]
17. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China]. Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis viruses and risk of cholangiocarcinoma in northeast Thailand. Srivatanakul P; Honjo S; Kittiwatanachot P; Jedpiyawongse A; Khuhaprema T; Miwa M Asian Pac J Cancer Prev; 2010; 11(4):985-8. PubMed ID: 21133611 [TBL] [Abstract][Full Text] [Related]
19. [The research progress in clinicopathological characteristics and treatment of hepatitis B virus-associated intrahepatic cholangiocarcinoma]. Tang ZH; Tong HJ; Quan ZW Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):280-283. PubMed ID: 32241057 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis. Zhou H; Wang H; Zhou D; Wang H; Wang Q; Zou S; Tu Q; Wu M; Hu H Eur J Cancer; 2010 Apr; 46(6):1056-61. PubMed ID: 20202823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]